文献速递胸部CT

放射组学列线图术前预测T1a-b期肺腺癌Ki-67增殖指数

Preoperative Ki-67 proliferation index prediction with a radiomics nomogram in stage T1a-b lung adenocarcinoma.
PubMed 文献 · Eur J Radiol · 2022-07-08

该回顾性研究纳入206例经病理确诊的T1a-b期肺腺癌患者,基于术前2周内CT提取放射组学特征构建列线图预测Ki-67高表达(>10%)。列线图在训练集和验证集的AUC分别为0.91和0.85,决策曲线分析显示具有临床实用性,可作为无创补充信息辅助治疗决策。

要点

  • 肿瘤最大径、分叶征、无空泡征及Radscore是高Ki-67表达的独立预测因子。
  • 列线图训练集AUC 0.91,验证集AUC 0.85,预测效能良好。
  • 该工具可在术前无创评估Ki-67增殖状态,辅助治疗方案选择。

关键影像表现/征象

  • 肿瘤最大径(P=0.005)、分叶征(P=0.002)、无空泡征(P<0.001)及Radscore(P<0.001)为高Ki-67表达的独立风险预测因子。

诊断标准与关键数值

  • Ki-67指数≤10%定义为低表达,>10%定义为高表达。
  • 列线图训练集AUC 0.91(95%CI: 0.86-0.96),敏感度87.9%,特异度80.5%,准确率83.4%。
  • 列线图验证集AUC 0.85(95%CI: 0.75-0.94),敏感度71.9%,特异度82.8%,准确率77.0%。

临床应用与阅片要点

  • 阅片时关注肿瘤最大径、分叶征及空泡征,结合Radscore可术前评估Ki-67高表达风险。
  • 列线图可作为无创补充工具,辅助T1a-b期肺腺癌治疗方案选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To establish a radiomics nomogram for preoperative prediction of Ki-67 proliferation index in stage T1a-b lung adenocarcinoma.

METHODS: A total of 206 patients with pathologically confirmed lung adenocarcinoma who underwent CT scans within 2 weeks preoperatively from January 2016 to June 2020 were retrospectively included. Ki-67 index ≤ 10% was considered low expression, and Ki-67 index > 10% was considered high expression. The primary cohort was randomized with a 7:3 ratio into a training cohort (n = 145) and a validation cohort (n = 61). The minimum redundancy maximum relevance (mRMR) and the least absolute shrinkage and selection operator (LASSO) were used for feature selection, and radiomics signature was constructed. Univariate and multivariate logistic regression analyses were used to identify clinically important risk factors and radiomics signature associated with Ki-67 proliferation index, which were then combined into radiomics nomogram.

RESULTS: Tumor maximum diameter (P = 0.005), lobulation (P = 0.002), absent of vacuole (P < 0.001), and Radscore (P < 0.001) were independent risk predictors of high Ki-67 proliferation index expression. The radiomics nomogram showed good predictive efficacy. The AUC, sensitivity, specificity and accuracy of radiomics nomogram in the training and validation cohorts were 0.91 (95% CI: 0.86-0.96), 87.9%, 80.5%, 83.4% and 0.85 (95% CI: 0.75-0.94), 71.9%, 82.8% and 77.0%. Decision curve analysis further demonstrated the clinical utility of the nomogram.

CONCLUSIONS: Radiomics nomogram provide a non-invasive method to predict Ki-67 proliferation index preoperatively in stage T1a-b lung adenocarcinoma, which might be the supplementary information for clinicians to choose the appropriate treatment program.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Bao, Liu, Ping, et al. Preoperative Ki-67 proliferation index prediction with a radiomics nomogram in stage T1a-b lung adenocarcinoma. Eur J Radiol. 2022. PMID: 35952476. doi:10.1016/j.ejrad.2022.110437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。